It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Outer hair cells (OHCs) are responsible for the amplification of sound, and the death of these cells leads to hearing loss. Although the mechanisms for sound amplification and OHC death have been well investigated, the effects on the cochlea after OHC death are poorly understood. To study the consequences of OHC death, we established an OHC knockout system using a novel mouse model, Prestin-hDTR, which uses the prestin promoter to express the human diphtheria toxin (DT) receptor gene (hDTR). Administration of DT to adult Prestin-hDTR mice results in the depletion of almost all OHCs without significant damage to other cochlear and vestibular cells, suggesting that this system is an effective tool for the analysis of how other cells in the cochlea and vestibula are affected after OHC death. To evaluate the changes in the cochlea after OHC death, we performed differential gene expression analysis between the untreated and DT-treated groups of wild-type and Prestin-hDTR mice. This analysis revealed that genes associated with inflammatory/immune responses were significantly upregulated. Moreover, we found that several genes linked to hearing loss were strongly downregulated by OHC death. Together, these results suggest that this OHC knockout system is a useful tool to identify biomarkers associated with OHC death.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Tokyo Metropolitan Institute of Medical Science, Mammalian Genetics Project, Setagaya-ku, Japan (GRID:grid.272456.0)
2 Tokyo Metropolitan Institute of Medical Science, Mammalian Genetics Project, Setagaya-ku, Japan (GRID:grid.272456.0); Tokyo University of Agriculture, Laboratory of Animal Resources and Development, Hokkaido, Japan (GRID:grid.410772.7)
3 Tokyo Metropolitan Institute of Medical Science, Mammalian Genetics Project, Setagaya-ku, Japan (GRID:grid.272456.0); Nagoya University, Division of Experimental Animals, Nagoya, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X)
4 Tokyo Metropolitan Institute of Medical Science, Advanced Technical Support Department, Setagaya-ku, Japan (GRID:grid.272456.0)
5 Tokyo Metropolitan Institute of Medical Science, Laboratory for Transgenic Technology, Setagaya-ku, Japan (GRID:grid.272456.0)